Long-Term Improvements Observed in Tralokinumab-Treated Patients with Moderate-to-Severe Atopic Dermatitis: an ECZTEND Interim Analysis. J of Skin [Internet]. 2021 Nov. 5 [cited 2025 May 18];5(6):s59. Available from: https://skin.dermsquared.com/skin/article/view/1410